Mauna Kea Technologies (Euronext: MKEA) inventor of Cellvizio^®, the multidisciplinary probe-based and needle-based confocal laser endomicroscopy (pCLE/ nCLE ) platform, today announced an amendment to the existing Debt Subscription Agreement with IPF Partners, a leading provider of alternative financing solutions. The amendment provides up to €10 million of additional borrowing capacity, in two tranches of €5 million each.